Abstract

The conviction that herbal drugs have enormous health benefits has led to increase the rate of their consumption by Nigerians. The aim of this study was to assess the carcinogenic property of some popularly consumed anti-diarrheal herbal drugs via polycyclic aromatic hydrocarbons (PAHs) quantification. Three prevalent anti-diarrhea herbal drugs , Odunmo herbal drug (Hibiscus rosa-sinensis and Bacopamonnieri), Orogun herbal mixture (Hibiscus sabdariffaI and Hedera helix), and Alora herbal syrup (Aloe vera and Hibiscus sabdariffaI) were bought for the purpose of this study and they were coded as samples A, B, and C, respectively. The ultrasonic extraction of the herbal drugs was carried out using standard procedures. The crude extracts obtained were purified using a chromatographic method. The concentrations of PAHs were quantified using gas chromatography flame ionization detector (GCFID). The diagnostic indices, group distribution, toxicity equivalence and exposure dosage were estimated. The cancer risk values were theoretically speculated based on concentrations of PAHs in the tested herbal drugs, associated with the published estimates of each concentration to cause cancer and the calculated exposure doses of the anti-diarrhea herbal drug samples were within three age groups (children, Preteen and adult). The highest concentration of total PAHs was observed in sample A (58.2815mg/kg) and the lowest concentration in sample B (44.1898mg/kg), but the concentration of total PAHs in sample C was 47.4169 mg/kg. The highest percentage of carcinogenic PAHs in the anti-diarrheal herbal drugs was found in sample C (48.66%) and the lowest in sample B (38.17%). The diagnostic indices confirmed a pyrogenic source of PAHs. Group distribution of PAHs showed that the herbal drugs are weakly carcinogenic due to high concentrations of low and moderate molecular weight PAHs. The cancer risk estimated for all the age groups where below the limit established by the United State Environmental Protection Agency (USEPA) for cancer (1 x 10-6). This ascertained that the use of these herbal drugs cannot cause cancer. However, consumers of these herbal drugs should take necessary precautions as excessive intake can lead to dangerous health implications.

Highlights

  • Diarrhea disease is characterized with an increase in frequency of bowel, vomiting, presence of blood in stools, loss of appetite, loss of weight, and abdominal pains, while cancer remains a major publicIraqi Journal of Science, 2021, Vol 62, No 4, pp: 1046-1053 health problem worldwide [1, 2]

  • Side effects arisen from the contamination of herbal drugs with heavy metals and polycyclic aromatic hydrocarbons were reported by Akintelu et al in 2018 [20]

  • The present study aimed at the carcinogenicity evaluation of randomly selected anti-diarrheal herbal drugs produced in Ondo State metropolis of Nigeria

Read more

Summary

Introduction

Diarrhea disease is characterized with an increase in frequency of bowel, vomiting, presence of blood in stools, loss of appetite, loss of weight, and abdominal pains, while cancer remains a major public. Easy accessibility, and low cost are the major advantages associated with the use of herbal drugs as remedy to diarrheal disease [17]. The eluent was collected drop wise into 100 ml test tubes They were spotted on thin layer chromatographic plates and those with similar retardation factor values where bulked and properly air dried to remove the eluting solvents by direct exposure to the atmosphere at room temperature. The obtained eluents were analyzed using GC-FID (Agilent 8860, Ukraine) to estimate the concentration of PAHs in the herbal drug samples. The analysis conditions included flow rate = 1.2 ml/min, column thickness = 1m, wavelength = 200 nm, temperature of column = 45°C, concentration of injected extract = 2 μl, mobile phase = helium and nitrogen gas, and method of elution = isocratic. USEPA TEF values were previously reported to be 0.1 for benzo[a] anthracene, 0.001 for chrysene, 0.1 for benzo[b] fluoranthene, 0.01 for benzo[k] fluoranthene, 1 for benzo[a] pyrene, 1 for dibenzo[a,h] anthracene, and 0.1 for indeno[1,2,3-c,d] pyrene [22]

Cancer risk evaluation
Pyrogenic Pyrogenic Pyrogenic
Group distribution of PAHs
Calculated exposure dose in samples
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.